The identifier "At1g17710" corresponds to a gene in the Arabidopsis thaliana genome. Genes labeled with "At" (e.g., At1g17710) are part of the standardized nomenclature for this model plant species. While the search results do not explicitly mention this gene or its associated antibody, general principles of antibody development and gene function can be inferred:
Antibody generation: Antibodies are typically raised against proteins encoded by specific genes, such as those involved in plant signaling or stress responses .
Gene function: Genes like At1g17710 may encode proteins of interest in plant biology, warranting antibody development for research purposes (e.g., protein localization, expression analysis).
If an antibody for At1g17710 exists, it would likely be used for:
Protein characterization: Detecting the expression of the At1g17710 protein in Arabidopsis tissues.
Functional studies: Investigating roles in plant development, pathogen responses, or abiotic stress pathways.
Interaction mapping: Identifying binding partners or post-translational modifications.
| Factor | Details |
|---|---|
| Absence in literature | No peer-reviewed studies or commercial catalogs cite this antibody. |
| Specificity concerns | Antibodies for plant genes often require custom development. |
| Validation requirements | Western blot, ELISA, or immunofluorescence data would be essential. |
Database queries: Check repositories like TAIR or UniProt for At1g17710 protein annotations.
Commercial suppliers: Contact antibody vendors (e.g., Agrisera, Thermo Fisher) for custom production.
Collaborative efforts: Partner with labs specializing in Arabidopsis proteomics.
While At1g17710 is not discussed, the sources highlight mechanisms relevant to antibody development:
Antibody diversity: Gene rearrangements (V(D)J recombination) and somatic hypermutation enable specificity .
Structural insights: Antibodies like bovine ultralong CDR H3s demonstrate unique antigen-binding adaptations .
High-throughput methods: Platforms like nanovials and single-cell sequencing accelerate antibody discovery .
The search results provided focus on AT1 receptor antibodies (Angiotensin II Type 1 Receptor) rather than the Arabidopsis thaliana gene At1g17710. Based on the available peer-reviewed data, below are research-focused FAQs addressing methodological challenges and advanced applications of AT1 receptor antibodies in academic contexts.
How can contradictory data from different AT1 receptor antibodies be resolved?
Orthogonal validation: Pair antibody-based results with functional assays (e.g., angiotensin II-induced blood pressure responses) .
Single-cell RNA sequencing: Profile immune cell populations in the tumor microenvironment to correlate receptor expression with functional outcomes .
Method comparison table:
What role do anti-AT1 receptor autoantibodies (AT1Rab) play in disease severity?
In COVID-19, AT1Rab-negative patients showed higher ICU admission rates (82.5%) and mortality (48.5%) compared to AT1Rab-positive patients .
Mechanism: AT1Rab may act as allosteric agonists, modulating ADAM17/IL-6 pathways and reducing cytokine storm severity .
Experimental design: Cohort studies comparing AT1Rab titers with clinical outcomes, adjusted for age/comorbidities .
How can computational modeling optimize AT1-targeted antibody dosing?